WREX Outcome Study

NCT02218593 | Completed Results

• 1 other identifier: 579772-2
• Study Type: observational
• Target: 25
• Locations: 0 countries
• Sites: N/A

Brief Summary

This study is to evaluate how the Wilmington Robotic Exoskeleton (WREX) is working for children who are using the WREX, or have used it in the past. The survey consists of a set of questions a) performed online and b) performed over the phone.

Conditions

Muscular Dystrophy; Arthrogryposis; Spinal Muscular Atrophy

Outcome Measures

Primary Outcomes (1)

• Canadian Occupational Performance Measure (COPM)

  Performance score on The Canadian Occupational Performance Measure (COPM). The total score range is 1-10. A score of 1 indicates indicates poor performance and low satisfaction and 10 indicates good performance and high satisfaction. The numbers indicate scores on a scale.

  Surveys were conducted at a single timepoint for each subject. The surveys were administered over a 4-month period for all the subjects.

Study Arms (1)

WREX orthosis

When the subject used the WREX Orthosis

Device: WREX orthosis

Interventions

WREX orthosis DEVICE

Upper extremity exoskleton used to assist movement

WREX orthosis

Eligibility Criteria

• Age: 2 Years - 21 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

People with Neuromuscular disease who use the Wilmington Robotic Exoskleton

You may qualify if:

• Neuromuscular disease
• Use the Wilmington Robotic Exoskeleton

You may not qualify if:

• people who do not use the Wilmington Robotic Exoskeleton

Sponsors & Collaborators

• Nemours Children's Clinic: lead

MeSH Terms

Conditions

Muscular Dystrophies; Arthrogryposis; Muscular Atrophy, Spinal

Condition Hierarchy (Ancestors)

Muscular Disorders, Atrophic; Muscular Diseases; Musculoskeletal Diseases; Neuromuscular Diseases; Nervous System Diseases; Genetic Diseases, Inborn; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Joint Diseases; Musculoskeletal Abnormalities; Congenital Abnormalities; Spinal Cord Diseases; Central Nervous System Diseases; Motor Neuron Disease; Neurodegenerative Diseases

Results Point of Contact

• Title: Director of Clinical Trials
• Organization: Nemours Children's Health

kristen.gibbs@nemours.org

4076507652

Publication Agreements

• PI is Sponsor Employee: Yes

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Prinicipal Research Engineer

Study Record Dates

• First Submitted: August 13, 2014
• First Posted: August 18, 2014
• Study Start: July 1, 2014
• Primary Completion: October 1, 2014
• Study Completion: July 1, 2015
• Last Updated: February 2, 2024
• Results First Posted: February 1, 2024

Record last verified: 2024-01